Hair Dye Under The Regulator’s Lens: Firms Scramble To Prove Safety Compliance

India’s apex drug authority has issued a strict directive for manufacturers to validate the safety of hair colour formulations amidst growing concerns over chemical exposure.

For millions of Indians, the monthly trip to the salon or the quick at-home touch-up is a mundane ritual to mask greys or refresh a look. Yet, that bottle of hair dye sitting on your bathroom shelf is now the subject of intense scrutiny. In a firm move to tighten oversight, the Central Drugs Standard Control Organisation (CDSCO) has directed manufacturers and importers to prove that their hair products strictly adhere to established safety norms, putting the spotlight on the complex chemistry of cosmetics.

The June circular serves as a stern reminder that the industry must align with the Cosmetics Rules, 2020, and the Bureau of Indian Standards (BIS). Regulators are demanding that companies move beyond mere sales and provide clear evidence that their products meet specific ingredient safety requirements. This includes mandatory labels, precise instructions for patch tests, and explicit caution statements designed to protect users from allergic reactions, skin irritation, and scalp sensitivity.

The Chemistry of Concern

At the heart of this regulatory push is the classification of ingredients. Under BIS standards—specifically IS 4707—substances are categorised into those deemed safe and those restricted or barred from cosmetic use. Companies, including major players like L’Oréal India, Godrej Consumer Products, Hindustan Unilever, and various D2C brands, must now ensure their ingredient lists are transparent. If a manufacturer alters a formulation, they are now obligated to report these changes to the relevant licensing authorities.

Globally, the debate over hair dye safety is far from settled. While the US FDA has moved to ban lead acetate in specific products and faces ongoing pressure from groups like Consumer Reports regarding volatile organic compounds, the Indian regulator is taking a preventive approach. By enforcing stricter compliance with BIS norms, the CDSCO is essentially demanding that firms prioritize consumer health over formulation secrecy, especially as products like P-phenylenediamine (PPD) continue to face expert scrutiny for their potential to trigger severe adverse effects.

Why it matters

This regulatory tightening is more than just paperwork; it signals a shift in how India treats personal care safety. As the domestic market for hair colour swells with younger users and an ageing population, the "buyer beware" era is fading. The CDSCO’s move forces brands to re-evaluate their supply chains and internal safety testing. For the average consumer, this means that while the products on the shelf aren't being recalled, the companies selling them are now under a microscope. Expect to see more rigorous labelling and, hopefully, a higher standard of accountability from the beauty giants who have long operated in a relatively grey area of health oversight.